Correlation Between PDS Biotechnology and Heron Therapeuti
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Heron Therapeuti at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Heron Therapeuti into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Heron Therapeuti, you can compare the effects of market volatilities on PDS Biotechnology and Heron Therapeuti and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Heron Therapeuti. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Heron Therapeuti.
Diversification Opportunities for PDS Biotechnology and Heron Therapeuti
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between PDS and Heron is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Heron Therapeuti in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heron Therapeuti and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Heron Therapeuti. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heron Therapeuti has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Heron Therapeuti go up and down completely randomly.
Pair Corralation between PDS Biotechnology and Heron Therapeuti
Given the investment horizon of 90 days PDS Biotechnology Corp is expected to generate 0.8 times more return on investment than Heron Therapeuti. However, PDS Biotechnology Corp is 1.26 times less risky than Heron Therapeuti. It trades about -0.24 of its potential returns per unit of risk. Heron Therapeuti is currently generating about -0.28 per unit of risk. If you would invest 312.00 in PDS Biotechnology Corp on August 24, 2024 and sell it today you would lose (92.00) from holding PDS Biotechnology Corp or give up 29.49% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
PDS Biotechnology Corp vs. Heron Therapeuti
Performance |
| Timeline |
| PDS Biotechnology Corp |
| Heron Therapeuti |
PDS Biotechnology and Heron Therapeuti Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PDS Biotechnology and Heron Therapeuti
The main advantage of trading using opposite PDS Biotechnology and Heron Therapeuti positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Heron Therapeuti can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heron Therapeuti will offset losses from the drop in Heron Therapeuti's long position.| PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
| Heron Therapeuti vs. Mereo BioPharma Group | Heron Therapeuti vs. Terns Pharmaceuticals | Heron Therapeuti vs. PDS Biotechnology Corp | Heron Therapeuti vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance |